Clinical-stage medtech making restorative polymer vascular grafts and heart valves.
| Date | Round | Amount |
|---|---|---|
| Aug 2023 | Funding round Eindhoven-based medtech Xeltis secured EUR12.5M from the European Innovation Council Fund for its restorative implants. | $13.4M |
| Feb 2023 | Series D Plus Xeltis raised a EUR32M Series D2 from Grand Pharma, DaVita Venture Group, EQT Life Sciences and Invest-NL for its restorative cardiovascular implants. | $32M |
| Aug 2022 | Series D Plus Dutch medtech Xeltis raised a 15M euro Series D2 from China's Grand Pharmaceutical Group, focused on its aXess hemodialysis access device. | $15M |
| Nov 2021 | Debt Swiss-Dutch medtech Xeltis secured EUR 15M in quasi-equity financing from the European Investment Bank to advance its restorative cardiovascular devices. | $17.7M |